Pediatric Drugs

Papers
(The TQCC of Pediatric Drugs is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Alirocumab: Pediatric First Approval76
Safety of Ferric Carboxymaltose in Children: Report of a Case Series from Greece and Review of the Literature61
Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department52
Pharmacogenetic Aspects of Drug Metabolizing Enzymes and Transporters in Pediatric Medicine: Study Progress, Clinical Practice and Future Perspectives42
Pain Management in Children: NSAID Use in the Perioperative and Emergency Department Settings36
Treatment Options for Alopecia Areata in Children and Adolescents33
Managing Lupus Nephritis in Children and Adolescents31
Gentamicin Pharmacokinetics in Neonates Undergoing Therapeutic Hypothermia for Hypoxic Ischemic Encephalopathy29
Optimizing Drug Selection in Children with Multiple Sclerosis: What Do We Know and What Remains Unanswered?27
Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized Study26
Perioperative Indications for Gabapentinoids in Pediatrics: A Narrative Review26
Intranasal Analgesia in Preterm and Term Neonates25
Acknowledgement to Referees25
Commercial Versus Compounded Preparations in Pediatric Ophthalmology24
A New Perspective on Drugs for Duchenne Muscular Dystrophy: Proposals for Better Respiratory Outcomes and Improved Regulatory Pathways24
Prevalence and Temporal Trends of Attention Deficit Hyperactivity Disorder Medication Fills During Pregnancy and Breastfeeding in Denmark23
New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products22
Real-World Data on the Use of Sirolimus in Asian Children with Vascular Malformations21
Low-Dose Remifentanil in Preterm Cesarean Section with General Anesthesia: A Randomized Controlled Trial20
Analysis of Risk Factors for Chloral Hydrate Sedative Failure with Initial Dose in Pediatric Patients: a Retrospective Analysis18
Improving Methylphenidate Titration in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): A Randomized Controlled Trial Using Placebo-Controlled Titration Implemented in Clinical Practice17
Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens–Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of16
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management15
Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients15
Recent Developments in the Treatment of Pediatric Distal Renal Tubular Acidosis15
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years15
Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents15
Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges14
Pharmacokinetics and Safety of Endotracheal Lidocaine for Endotracheal Intubation in Critically Ill Children14
Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date13
Dose Rationale of Nasal Glucagon in Japanese Pediatric Patients with Diabetes Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation13
Immunotherapies for Pediatric Solid Tumors: A Targeted Update13
Inotuzumab Ozogamicin: First Pediatric Approval13
Learning-Based Models for Predicting IVIG Resistance and Coronary Artery Lesions in Kawasaki Disease: A Review of Technical Aspects and Study Features13
Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients13
Enhancing Mood, Cognition, and Quality of Life in Pediatric Multiple Sclerosis12
Oral Ibuprofen for the Treatment of PDA in Preterm Neonates: Urgent Need for a Safer Alternative to Hyperosmolar Formulations12
Interventions to Reduce Pediatric Prescribing Errors in Professional Healthcare Settings: A Systematic Review of the Last Decade11
Targeted Treatments for Myasthenia Gravis in Children and Adolescents11
An Update of Pharmacological Management in Children with Functional Constipation11
Best Evidence-Based Dosing Recommendations for Dexmedetomidine for Premedication and Procedural Sedation in Pediatrics: Outcome of a Risk-Benefit Analysis By the Dutch Pediatric Formulary10
Correction to: Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis10
Population Pharmacokinetics and Dose Optimization of Piperacillin in Infants and Children with Pneumonia10
Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors10
Comparison of Deep and Moderate Neuromuscular Blockade for Major Laparoscopic Surgery in Children: A Randomized Controlled Trial10
Adverse Event Profile of First-line Drugs for Treating Patent Ductus Arteriosus in Neonates: A Disproportionality Analysis Study of USFDA Adverse Event Reporting System10
Emerging Treatments in Neonatal Fungal Infections: Progress and Prospects10
Off-Label Use of Anakinra in Inflammatory Conditions in Neonates and Infants Up to 3 Months of Age: A Case Series and a Review of the Literature10
Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN9
Insulin Glargine 300 U/mL Therapy in Children and Adolescents with Type 1 Diabetes9
Toxicity Spectrum of Anti-GD2 Immunotherapy: A Real-World Study Leveraging the US Food and Drug Administration Adverse Event Reporting System9
Medical Management of Infantile Hemangiomas: An Update9
Prevalence and Perinatal Outcomes Following In Utero Exposure to Prehospital Emergency Methoxyflurane: A 17-Year Retrospective Cohort Study8
An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus8
Acute Tolerability of Methylphenidate in Treatment-Naïve Children with ADHD: An Analysis of Naturalistically Collected Data from Clinical Practice8
Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of Four Randomized Clin8
Neuroimaging as a Tool for Advancing Pediatric Psychopharmacology8
Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review8
Emerging Treatments for Childhood Interstitial Lung Disease8
Dual-Targeted Therapy in Pediatric Inflammatory Bowel Disease: A Comprehensive Review8
Phentermine/Topiramate: Pediatric First Approval8
Safety and Efficacy of Ledipasvir/Sofosbuvir in the Treatment of Chronic Hepatitis C Virus Infection in Treatment-Naïve Children without and with Comorbidities8
Mechanistic Links Between Obesity and Airway Pathobiology Inform Therapies for Obesity-Related Asthma8
Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A Systematic Review8
Prescription Trends for Primary Headache in Children and Adolescents in China During 2019–2023: A Retrospective Study8
0.035098791122437